# US 2026/0183456 A1 · Apparatuses and methods for treating ophthalmic diseases and disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0183456 A1
- Document ID: US20260183456A1
- Status: Published application
- Kind: A1
- Application number: 19/400,523
- Filed: 2025-11-25
- Published: 2026-07-02
- Earliest claimed: 2015-02-23
- Assignees: Biotissue Holdings Inc.
- Applicants: BioTissue Holdings Inc.
- Inventors: Scheffer TSENG; Ek Kia TAN
- Web page: https://patentgrep.com/patent/US20260183456A1

## CPC

- A61L 31/005: {Ingredients of undetermined constitution or reaction products thereof}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61P 27/02: Ophthalmic agents
- A61L 2300/406: Antibiotics
- A61L 2430/16: for reconstruction of eye parts, e.g. intraocular lens, cornea
- A61N 1/0452: {Specially adapted for transcutaneous muscle stimulation [TMS]}
- A61N 1/36003: {of motor muscles, e.g. for walking assistance}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The invention relates generally to the fields of biology and health sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and pathological processing using a combination of compounds that can be found in amniotic membrane tissue and umbilical cord tissue preparations.

## Claims

### Claim 1

An ophthalmic device comprising a flexible tubular structure, wherein the flexible tubular structure is configured for insertion into a fornix of an eye, wherein the flexible tubular structure further comprises an amniotic membrane tissue, an umbilical cord tissue, a placental tissue, or a chorion tissue; and wherein the flexible tubular structure is configured to dissolve when in contact with tears, whereupon the amniotic membrane tissue, the umbilical cord tissue, the placental tissue, or the chorion tissue is released from the flexible tubular structure and contacts the surface of the eye.

### Claim 2 (depends on 1)

The ophthalmic device of claim 1, wherein the flexible tubular structure comprises an amniotic membrane tissue or an umbilical cord tissue.

### Claim 3 (depends on 1)

The ophthalmic device of claim 1, wherein the flexible tubular structure comprises a placental tissue or a chorion tissue.

### Claim 4 (depends on 1)

The ophthalmic device of claim 1, wherein the fornix is a superior conjunctiva fornix or an inferior conjunctiva fornix.

### Claim 5 (depends on 1)

The ophthalmic device of claim 1, wherein the flexible tubular structure further comprises at least one porous inlet and at least one porous outlet.

### Claim 6 (depends on 5)

The ophthalmic device of claim 5, wherein the at least one porous inlet and the at least one porous outlet form an osmotic pump when in contact with tears in the eye.

### Claim 7 (depends on 1)

The ophthalmic device of claim 1, wherein the amniotic membrane tissue, umbilical cord tissue, placental tissue or chorion tissue are fresh or previously frozen.

### Claim 8 (depends on 1)

The ophthalmic device of claim 1, wherein the amniotic membrane tissue, umbilical cord tissue, placental tissue or chorion tissue are an extract, lyophilized, powdered, or morselized.

### Claim 9 (depends on 1)

The ophthalmic device of claim 1, wherein any of the amniotic membrane tissue, umbilical cord tissue, placental tissue or chorion tissue is a sheet.

### Claim 10 (depends on 1)

The ophthalmic device of claim 1, wherein the flexible tubular structure is annular in shape.

### Claim 11 (depends on 10)

The ophthalmic device of claim 10, wherein the ophthalmic device further comprises an AM, UC, placental, or chorion tissue sheet attached thereto.

### Claim 12 (depends on 11)

The ophthalmic device of claim 11, wherein the AM, UC, placental, or chorion tissue sheet are configured to contact the surface of the eye.

### Claim 13 (depends on 1)

The ophthalmic device of claim 1, wherein the device induces blinking.

### Claim 14 (depends on 1)

The ophthalmic device of claim 1, wherein the device comprises at least one additional therapeutically active agent.

### Claim 15 (depends on 14)

The ophthalmic device of claim 14 wherein the least one additional therapeutically active agent comprises an antibacterial antibiotic, a synthetic antibacterial, an antifungal antibiotic, a synthetic antifungal, an antineoplastic agent, a steroidal anti-inflammatory agent, a non-steroidal anti-inflammatory agent, a tissue preparation, an anti-allergic agent, a glaucoma-treating agent, an antiviral agent, an anti-mycotic agent, or any combination thereof.

### Claim 16 (depends on 1)

A method of treating a disease or disorder of an eye of an individual in need thereof, the method comprising administering the ophthalmic device of claim 1 to the eye of the individual in need thereof, thereby treating the disease or disorder of the eye.

### Claim 17 (depends on 16)

The method of claim 16, wherein the device is administered concurrently with the at least one additional therapeutically active agent.

### Claim 18 (depends on 17)

The method of claim 17, wherein the at least one additional therapeutically active agent comprises an antibacterial antibiotic, a synthetic antibacterial, an antifungal antibiotic, a synthetic antifungal, an antineoplastic agent, a steroidal anti-inflammatory agent, a non-steroidal anti-inflammatory agent, a tissue preparation, an anti-allergic agent, a glaucoma-treating agent, an antiviral agent, an anti-mycotic agent, or any combination thereof.

### Claim 19 (depends on 16)

The method of claim 16, wherein the ophthalmic device (i) induces the individual to blink and tear more frequently to prevent dry eye, (ii) increases nerve growth, wherein the increase in nerve growth is between about 10% and about 100%, (iii) increases nerve regeneration, wherein the increase in nerve regeneration is between about 10% and about 100%, (iv) promotes an increase in tissue sensation, (v) reduces an inflammatory response in a contacted tissue, (vi) increases tear breakup time in an individual suffering from dry eye disease, (vii) increases tear osmolality in an individual suffering from dry eye disease, (viii) decreases corneal straining in an individual suffering from dry eye disease, (ix) increases the score on Schirmer's test in an individual suffering from dry eye disease, or combinations thereof.

### Claim 20 (depends on 16)

The method of claim 16, wherein the disease or disorder of the eye of the individual comprises dry eye disease or other ophthalmic diseases or disorders.
